Genetic predispositions, including polymorphisms I148M of PNPLA3 and E167K of TM6SF2, have been implicated in increasing susceptibility to NAFLD. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.